The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak

ZÜBARİOĞLU T., HOPURCUOĞLU D., Uygur E., AHMADZADA S., Oge-Enver E., İŞAT E., ...More

TELEMEDICINE AND E-HEALTH, vol.28, pp.258-265, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 28
  • Publication Date: 2022
  • Doi Number: 10.1089/tmj.2020.0569
  • Journal Name: TELEMEDICINE AND E-HEALTH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, Compendex, EMBASE, MEDLINE, Psycinfo
  • Page Numbers: pp.258-265
  • Istanbul University Affiliated: Yes

Abstract

Background: The prognosis of phenylketonuria (PKU) in terms of neurocognitive outcome is directly related to lifelong phenylalanine (Phe) levels and adherence to treatment. Monitoring and treatment of PKU patients can be complicated in challenging circumstances as pandemics. This study aims to evaluate the impact of telemedicine for monitoring and treatment of PKU patients on metabolic outcome during coronavirus disease-19 (COVID-19) outbreak.